Prostate Medicines Linked to Type-2 Diabetes: Study
Medicines which help reduce symptoms of prostate disease, increase risk of type-2 diabetes.
Medicines which help reduce symptoms of prostate disease, increase risk of type-2 diabetes. (Photo: iStockphoto)

Prostate Medicines Linked to Type-2 Diabetes: Study

Medicines prescribed to reduce the symptoms of prostate diseases increase the likelihood of developing Type-2 diabetes.

A study found that the drugs increased the risk of developing the disorder by about 30 percent. In addition, a similar effect was seen when repeated with health records from a group of Taiwanese men.

Also Read : Researchers Develop New Prostate Cancer Prediction Tool: Study

Men with enlarged prostates are commonly prescribed the drugs called 5-alpha-reductase inhibitors that reduce the production of hormones called androgens. These help treat symptoms such as reduced urinary flow. The study's findings suggested that men taking these medications may need additional health checks to monitor warning signs of diabetes so that their prescriptions can be altered if necessary.

We found that commonly prescribed medications for prostate disease can increase the risk of Type-2 diabetes. These findings will be particularly important for health screening in older men who are already typically at a higher risk of Type-2 diabetes.
Ruth Andrew, Professor at the University of Edinburgh, Scotland.

"It is important that all patients are made aware of the risks and benefits of their medications," noted Li Wei, Associate Professor at the UCL School of Pharmacy in Britain.

For the study, the team studied health records from around 55,000 men who were prescribed 5-alpha-reductase inhibitors.

Also Read : How Type 2 Diabetes Turned My Life Upside Down

(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT)

Follow our Diabetes section for more stories.

    Also Watch